serious trust deficit with TPAC shareholders and mgmt/IR
serious trust deficit with TPAC shareholders and mgmt/IR right now. a lot of "enthusiasm" on the board but very little to know buying let alone aggressive buying.
VNDM remains on the ASK with the 10K offer with another 10MM shares ahead of it. while those blocks can certainly be fake walls - they are able to play the game because of the lack of buying with any intent. i bought the 1s offered on the ASK earlier as i did the week prior but right now, i see those as a short term play. unfortunately, i am do not believe the VNDM selling is retail/naked shorting/MM and believe it is continued dilution. it is supported by increase in OS.
at this point - i do not see any PR creating a sustained increase in PPS due to the heavy dilution since VNDM showed up (which wasnt long after the IRMuse handle). there are a lot of shares that have been more than likely added to the float and while long term shareholders may have absorbed some (maybe a majority?), there will be a lot of flipping preventing this from creating a significantly higher base. worse, if VNDM is NOT off the ASK when anything substantial is announced, there will be aggressive shorting knocking the price back down quickly in the absence of sustained, determined buying.
so - who is going to do that sustained, determined buying...? long term shareholders are tapped out/guarded right now. potential new investors dont know the company exists/potential and/or are waiting for the churning to subside. how does the company break out of this trading range/churning quagmire? when does revenue increase to the point that further dilution can be removed as a constant threat? if the company has to continue to rely on debt offerings to pay IR, legal, contractors, cover SG&A and the price keeps tanking - OS starts converging on AS. this is where revenue guidance (specifically the ramp up) becomes critical to real, long term investors. cash flow eliminates the need for toxic and/or short term debt and instead allows long term, attractive funding at which point investors feel substantially more confident.
when OS was decreasing (apparently...?) end of 2015/beginning of 2016 - that was reflected in increased confidence and buying. when will it be restored?
i appreciate the private replies to my posts (both agreeing and disagreeing) but i still believe the lack of transparency with IR, VNDM constant selling, and lack of PRs opening up $TPAC to a larger audience will continue to be a major drag on PPS and encourage short term traders/flippers instead of attracting/enticing long term investors.
9
Trans-Pacific Aerospace (TPAC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of the 2024 Universal Registration Document AVAILABILITY OF THE 2024 UNIVERSAL REGISTRATION DOCUMENT We are excited to announce that Tarkett has completed the filing of its 2024 Universal Registration Document with the Autorité des Marchés Financiers (AMF). This comprehensive document, made accessible to the public, outlines our financial activities and...
Continue Reading
After-Hours Stock Movements The stock market often experiences fluctuations after regular trading hours, reflecting new earnings reports and investor reactions. This trend is continually observed across various companies, impacting their stock values significantly. Electronic Arts Earnings Update Electronic Arts (NASDAQ: EA) faced a decline of 6.75% following the...
Continue Reading
A New Era for Fort Douglas The dusty heart of the Wasatch foothills, long tied to both military rigor and academic growth, is singing a new tune. It feels like yesterday that the University of Utah and the U.S. Army Reserve were odd neighbors; now they're embarking on a joint venture that holds more promise than a hot tip from Wall Street. After over a century, more than...
Continue Reading
SailPoint Prepares for Earnings Release SailPoint, Inc. (NASDAQ: SAIL) is gearing up to unveil its earnings results for the third quarter. Investors eagerly await insights into the company's performance, which is scheduled to be announced before the market opens on an upcoming date in December. Analyst Predictions for SailPoint's Earnings Analysts project that SailPoint...
Continue Reading
Enerpac Tool Group Shares Decline Significantly Enerpac Tool Group Corp. (NYSE: EPAC) faced a challenging moment in the market as shares dropped by 9% following the release of their fourth-quarter earnings report. Investors were left disappointed as the industrial tools manufacturer reported results that fell short of analyst expectations. Quarterly Earnings Overview For...
Continue Reading